Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gillies

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
World Journal of Stem Cells|November 12, 2020
Enrichment of retinal ganglion and Müller glia progenitors from retinal organoids derived from human induced pluripotent stem cells - possibilities and current limitationsKristine Karla Freude, Sarkis Saruhanian, Alanna McCauley, et al.
Ophthalmology. Retina|April 25, 2019
A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! CohortKelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2024
Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin StudyChristopher C Karayiannis, Velandai Srikanth, Richard Beare, et al.
Eye (London, England)|March 26, 2021
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, David Squirrell, Vuong Nguyen, et al.
Investigative Ophthalmology & Visual Science|August 4, 2018
Choroidal Structural Changes Correlate With Neovascular Activity in Neovascular Age Related Macular DegenerationAlessandro Invernizzi, Eleonora Benatti, Mariano Cozzi, et al.
Acta Ophthalmologica|December 20, 2022
Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registryJorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, et al.
Retina (Philadelphia, Pa.)|March 2, 2019
ASSESSING THE ACCURACY OF A LARGE OBSERVATIONAL REGISTRY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONVuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, et al.
Clinical & Experimental Ophthalmology|May 9, 2020
Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! RegistryAnne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, et al.
Ophthalmology. Retina|June 4, 2025
TALON Phase IIIb Study: 32-Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age-Related Macular DegenerationCarl Regillo, Peter K Kaiser, Peter J Kertes, et al.
The Journal of Bone and Joint Surgery. American Volume|November 15, 2008
Squeaking hipsWilliam L Walter, Tim S Waters, Mark Gillies, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
World Journal of Stem Cells|November 12, 2020
Enrichment of retinal ganglion and Müller glia progenitors from retinal organoids derived from human induced pluripotent stem cells - possibilities and current limitationsKristine Karla Freude, Sarkis Saruhanian, Alanna McCauley, et al.
Ophthalmology. Retina|April 25, 2019
A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! CohortKelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2024
Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin StudyChristopher C Karayiannis, Velandai Srikanth, Richard Beare, et al.
Eye (London, England)|March 26, 2021
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, David Squirrell, Vuong Nguyen, et al.
Investigative Ophthalmology & Visual Science|August 4, 2018
Choroidal Structural Changes Correlate With Neovascular Activity in Neovascular Age Related Macular DegenerationAlessandro Invernizzi, Eleonora Benatti, Mariano Cozzi, et al.
Acta Ophthalmologica|December 20, 2022
Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registryJorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, et al.
Retina (Philadelphia, Pa.)|March 2, 2019
ASSESSING THE ACCURACY OF A LARGE OBSERVATIONAL REGISTRY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONVuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, et al.
Clinical & Experimental Ophthalmology|May 9, 2020
Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! RegistryAnne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, et al.
Ophthalmology. Retina|June 4, 2025
TALON Phase IIIb Study: 32-Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age-Related Macular DegenerationCarl Regillo, Peter K Kaiser, Peter J Kertes, et al.
The Journal of Bone and Joint Surgery. American Volume|November 15, 2008
Squeaking hipsWilliam L Walter, Tim S Waters, Mark Gillies, et al.
Pageof 12